The Aftermath of US Withdrawal from the Iran Agreement
A new report from the Congressional Research Service begins to sort through the implications and the practical consequences of the Trump Administration decision to end US compliance with the Iran nuclear agreement, known as the Joint Comprehensive Plan of Action (JCPOA).
“The Trump Administration could have used provisions of the JCPOA itself to cease implementation of U.S. commitments under the agreement. It opted not to do so, but instead to cease implementing the JCPOA by reimposing U.S. sanctions,” the CRS report noted.
See U.S. Decision to Cease Implementing the Iran Nuclear Agreement, May 9, 2018.
For related background from CRS, see also Iran: U.S. Economic Sanctions and the Authority to Lift Restrictions, updated May 10, 2018; Withdrawal from International Agreements: Legal Framework, the Paris Agreement, and the Iran Nuclear Agreement, updated May 4, 2018; and Iran Nuclear Agreement, updated May 2, 2018.
The decision to unilaterally reimpose sanctions on Iran took the form of a National Security Presidential Memorandum (NSPM) on May 8. Although the NSPM posted on the White House website is unnumbered, the copy circulated to reporters was identified as NSPM-11.
It follows that the previous NSPM on conventional arms transfers, which was also unnumbered on the White House website, must have been NSPM 10.
Other new and updated reports from the Congressional Research Service include the following.
Arms Control and Nonproliferation: A Catalog of Treaties and Agreements, updated May 8, 2018
Military Suicide Prevention and Response, CRS In Focus, April 30, 2018
Oil and Gas Activities Within the National Wildlife Refuge System, May 9, 2018
Civilian Nuclear Waste Disposal, updated May 9, 2018
High Intensity Drug Trafficking Areas (HIDTA) Program, May 3, 2018
From Slip Law to United States Code: A Guide to Federal Statutes for Congressional Staff, May 2, 2018
Covert Action and Clandestine Activities of the Intelligence Community: Selected Notification Requirements in Brief, May 7, 2018
The Director of National Intelligence (DNI), CRS In Focus, May 1, 2018
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.
Grant funds research of AI’s impact on nuclear weapons, biosecurity, military autonomy, cybersecurity, and other global issues.
AdComm members note a lack of transparency in recruitment methods, insufficient training, and limited understanding of regulatory procedures.
Internal disagreements present a growing concern about FDA leadership overruling the expert opinions of scientific staff and proceeding with official approvals, thus undermining staff expertise, decreasing agency morale, and potentially diminishing public trust.